封装细胞技术:提供细胞因子来治疗后眼部疾病
Jiale Wang1, Wenhui Fan1, Bo Liu1
1Department of Ophthalmology, Henan Eye Hospital, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, China; College of Medicine, Zhengzhou University, Zhengzhou 450001, China.
Pharmacological research
|March 30, 2024
概括
封装细胞技术 (ECT) 通过输送治疗性细胞因子,为治疗后部眼部疾病提供了一种有前途的方法. 这种有针对性的输送系统克服了生物障碍,提供了持续释放和一种比眼内基因治疗更安全的替代方案.
科学领域:
- 眼科医生 眼科 眼科
- 生物技术是生物技术.
- 药物输送系统 药物输送系统
背景情况:
- 由于生物障碍,局部药物管理面临着在眼睛后部达到治疗度的挑战.
- 封装细胞技术 (ECT) 在半透囊中利用基因工程细胞,以有针对性地输送治疗剂.
- 电电疗法已显示出治疗后部段疾病的巨大潜力,与传统方法相比,它提供了优势.
研究的目的:
- 审查封装细胞技术 (ECT) 在治疗后部眼部疾病中的应用和潜力.
- 突出ECT的优势,包括克服生物障碍,并使治疗性细胞因子的持续释放.
- 讨论ECT的安全性和可逆性,作为眼内基因疗法的替代方案.
主要方法:
- 对2000年至2024年3月期间发表的科学文献进行审查.
- 在数据库中进行文献搜索:PubMed/MEDLINE,谷歌学者,科克兰图书馆和科学网.
- 对聚焦封装细胞技术用于后段疾病治疗的研究进行评估.
主要成果:
- 电磁透使生长因子和细胞因子通过透性封装材料有效地扩散到视网膜组织中.
- 该技术允许治疗剂的持续释放,在后部部位达到有效度.
- ECT提供一种可逆的治疗选择,可及时取出植入物,提高眼内基因疗法的安全性.
结论:
- 封装细胞技术为退行性视网膜病变提供了一个有前途的治疗策略,包括干燥的与年龄相关的黄斑退行 (AMD),视网膜色素炎 (RP),玻璃眼和黄斑长视线病 (MacTel).
- 封装材料和保存技术的优化对于稳定有效的细胞因子的长期释放至关重要.
- 电感疗法对推进各种后段眼部疾病的治疗具有重大前景,丰富了眼内基因疗法领域.
相关概念视频
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


